ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.

Thursday 18 January, 2024
Next Generation Sequencing (NGS) assay and software to screen, to genotype and to discriminate the Human Papillomavirus.ABL Diagnostics strives to offer innovative solutions providing to healthcare personnel relevant information about high-risk HPV types which are known to cause genital warts or cancer…
Read More